Yahoo! Finance Search - Finance Home - Yahoo! - Help

Friday, July 3 2015 11:40am ET - U.S. Markets close in 4 hours and 20 minutes.
Industry Center - Biotechnology
Industry Center > Biotechnology > News
More On This Industry
· Summary
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Biotechnology News
Latest News
Friday, Jul 3, 2015
·Sarepta Therapeutics One Step Closer to Drug Approval
at Investopedia - 45 minutes ago
·Celgene's $1 Billion Deal to Fight Cancer
at Investopedia - 51 minutes ago
·AAIC Is Coming: Here's What To Expect, Biogen And Eli Lilly Investors
- 1 hour, 18 minutes ago
·SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Puma Biotechnology, Inc. of Class Action Lawsuit and Upcoming Deadline - PBYI
PR Newswire - 2 hours, 40 minutes ago
·Japan’s Ministry of Health, Labour and Welfare Approves Gilead’s Harvoni®, the First Once-Daily Single Tablet Regimen for the Treatment of Genotype 1 Chronic Hepatitis C
Business Wire - Fri 2:00 am ET
Thursday, Jul 2, 2015
·Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against Celladon Corporation
PR Newswire - Thu 10:00 pm ET
·EQUITY ALERT: The Rosen Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Celladon Corporation
Business Wire - Thu 6:53 pm ET
·Navidea Biopharmaceuticals and Macrophage Therapeutics to Host Post-International KSHV Conference Summary Webcast
Business Wire - Thu 6:12 pm ET
·NeuroDerm Ltd. Files Registration Statement for Proposed Follow-On Offering
GlobeNewswire - Thu 5:40 pm ET
·Xoom Zooms, Teladoc Sinks a Day After Debut -- Tech Winners and Losers
at - Thu 5:05 pm ET
·Vertex Investors Sigh at FDA Approval
at Motley Fool - Thu 5:01 pm ET
·FDA clears drug for leading form of cystic fibrosis
AP - Thu 4:50 pm ET
·ADDING MULTIMEDIA FDA Approves ORKAMBI™ (lumacaftor/ivacaftor) - the First Medicine to Treat the Underlying Cause of Cystic Fibrosis for People Ages 12 and Older with Two Copies of the F508del Mutation
Business Wire - Thu 4:50 pm ET
·3 Experimental Cancer Drugs Investors Should Be Closely Watching
at Motley Fool - Thu 4:45 pm ET
·Vertex's Orkambi Approved For CF, Prices On High Side
at Investor's Business Daily, Inc. - Thu 4:34 pm ET
·Theravance Biopharma Announces New Employment Inducement Awards
Marketwire - Thu 4:30 pm ET
·Bernard M. Gross P.C. Files Class Action Lawsuit Against Celladon Corporation -- CLDN
GlobeNewswire - Thu 4:17 pm ET
·Revance Therapeutics Announces Change in Role of Jacob Waugh, M.D.
GlobeNewswire - Thu 4:06 pm ET
·Ignyta to Present at Cantor Fitzgerald Healthcare Conference
Business Wire - Thu 4:00 pm ET
·Vertex Pharmaceuticals: Now That's an Approval!
at - Thu 3:58 pm ET
More Latest News...
Sponsor Results
Rare Disease Pipeline
Alexion develops therapies for patients with severe rare diseases.
Shimadzu Life Science
Develop, Accelerate, Integrate with All Your Life Science Needs
Biotechnology News
New SDN Uses for Lan, Wan and Data Centers. Expert Tips.
(What's This?)

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Biotechnology Headlines
More Finance RSS Feeds

Copyright © 2015 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2015 Morningstar, Inc. All Rights Reserved. Company information © 2015 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2015, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?